| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 881 | 2021 |
| 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016 Y Allenbach, AL Mammen, O Benveniste, W Stenzel, A Amato, A Aussey, ... Neuromuscular disorders 28 (1), 87-99, 2018 | 424 | 2018 |
| Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies K Mariampillai, B Granger, D Amelin, M Guiguet, E Hachulla, F Maurier, ... JAMA neurology 75 (12), 1528-1537, 2018 | 355 | 2018 |
| Abatacept for severe immune checkpoint inhibitor–associated myocarditis JE Salem, Y Allenbach, A Vozy, N Brechot, DB Johnson, JJ Moslehi, ... New England Journal of Medicine 380 (24), 2377-2379, 2019 | 340 | 2019 |
| Long-term observational study of sporadic inclusion body myositis O Benveniste, M Guiguet, J Freebody, O Dubourg, W Squier, ... Brain 134 (11), 3176-3184, 2011 | 321 | 2011 |
| Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology MP Bonaca, BA Olenchock, JE Salem, SD Wiviott, S Ederhy, A Cohen, ... Circulation 140 (1), 80-91, 2019 | 315 | 2019 |
| Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin Y Allenbach, L Drouot, A Rigolet, JL Charuel, F Jouen, NB Romero, ... Medicine 93 (3), 150-157, 2014 | 312 | 2014 |
| Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer M Touat, T Maisonobe, S Knauss, O Ben Hadj Salem, B Hervier, K Auré, ... Neurology 91 (10), e985-e994, 2018 | 304 | 2018 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 273 | 2021 |
| High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody Y Allenbach, J Keraen, A Bouvier, V Jooste, N Champtiaux, B Hervier, ... Brain 139 (8), 2131-2135, 2016 | 255 | 2016 |
| High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic … Y Allenbach, R Seror, C Pagnoux, L Teixeira, P Guilpain, L Guillevin, ... Annals of the rheumatic diseases 68 (4), 564-567, 2009 | 227 | 2009 |
| 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018 AL Mammen, Y Allenbach, W Stenzel, O Benveniste, J De Bleecker, ... Neuromuscular Disorders 30 (1), 70-92, 2020 | 198 | 2020 |
| JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis L Ladislau, X Suárez-Calvet, S Toquet, O Landon-Cardinal, D Amelin, ... Brain 141 (6), 1609-1621, 2018 | 196 | 2018 |
| Interleukin‐21 modulates Th1 and Th17 responses in giant cell arteritis B Terrier, G Geri, W Chaara, Y Allenbach, M Rosenzwajg, ... Arthritis & Rheumatism 64 (6), 2001-2011, 2012 | 193 | 2012 |
| EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors M Kostine, A Finckh, CO Bingham, K Visser, J Leipe, H Schulze-Koops, ... Annals of the rheumatic diseases 80 (1), 36-48, 2021 | 185 | 2021 |
| Immune-mediated necrotizing myopathy: clinical features and pathogenesis Y Allenbach, O Benveniste, W Stenzel, O Boyer Nature Reviews Rheumatology 16 (12), 689-701, 2020 | 172 | 2020 |
| Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis L Mescam-Mancini, Y Allenbach, B Hervier, H Devilliers, K Mariampillay, ... Brain 138 (9), 2485-2492, 2015 | 170 | 2015 |
| Immune checkpoint inhibitor–associated myositis: expanding the spectrum of cardiac complications of the immunotherapy revolution C Anquetil, JE Salem, B Lebrun-Vignes, DB Johnson, AL Mammen, ... Circulation 138 (7), 743-745, 2018 | 167 | 2018 |
| Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement Y Allenbach, L Arouche-Delaperche, C Preusse, H Radbruch, ... Neurology 90 (6), e507-e517, 2018 | 159 | 2018 |
| Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases Y Allenbach, Y Uzunhan, S Toquet, G Leroux, L Gallay, A Marquet, ... Neurology 95 (1), e70-e78, 2020 | 157 | 2020 |
